StonvexLoading…
StonvexStonvexStonvexCore line items from SCYX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $20.60M | $3.75M | $140.14M | $5.09M |
Operating Income | $-16.07M | $-37.12M | $72.67M | $-85.76M |
Net Income | $-8.61M | $-21.29M | $67.04M | $-62.81M |
EPS (Diluted) | $-0.17 | $-0.44 | $1.39 | $-1.47 |
Total Assets | $59.03M | $90.64M | $128.41M | $87.81M |
Total Liabilities | $9.65M | $35.57M | $55.45M | $84.58M |
Cash & Equivalents | $21.26M | $16.05M | $34.05M | $45.81M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 43.54M | 37.97M | 37.21M | 32.68M |